TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis

Stéphane Cauchi1, Youness El Achhab2, Hélène Choquet1, Christian Dina1, Franz Krempler3, Raimund Weitgasser4, Chakib Nejjari2, Wolfgang Patsch5, Mohamed Chikri6, David Meyre1, Philippe Froguel7
1CNRS, 8090, Institute of Biology, Pasteur Institute, Lille, 59000, France
2Laboratory of Epidemiology, Faculty of Medicine and Pharmacy of Fez, Route Sidi Harazem, B.P 1893, Fez, Morocco
3Department of Internal Medicine, Krankenhaus Hallein, Hallein, Austria
4Department of Internal Medicine, Paracelsus Medical University and Landeskliniken Salzburg, A-5020, Salzburg, Austria
5Department of Laboratory Medicine, Paracelsus Medical University and Landeskrankenhaus Salzburg, Salzburg, Austria
6Laboratory of Biochemistry, Faculty of Medicine and Pharmacy of Fez, Fez, Morocco
7Section of Genomic Medicine, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W12 0NN, UK

Tóm tắt

Từ khóa


Tài liệu tham khảo

Grant SF, Thorleifsson G, Reynisdottir I et al (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38:320–323

Scott LJ, Bonnycastle LL, Willer CJ et al (2006) Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample. Diabetes 55:2649–2653

Groves CJ, Zeggini E, Minton J et al (2006) Association analysis of 6,736 U.K. subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk. Diabetes 55:2640–2644

Saxena R, Gianniny L, Burtt NP et al (2006) Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 55:2890–2895

Cauchi S, Meyre D, Dina C et al (2006) Transcription factor TCF7L2 genetic study in the french population: expression in human {beta}—cells and adipose tissue and strong association with type 2 diabetes. Diabetes 55:2903–2908

van Vliet-Ostaptchouk JV, Shiri-Sverdlov R, Zhernakova A et al (2007) Association of variants of transcription factor 7-like 2 (TCF7L2) with susceptibility to type 2 diabetes in the Dutch Breda cohort. Diabetologia 50:59–62

Humphries SE, Gable D, Cooper JA et al (2006) Common variants in the TCF7L2 gene and predisposition to type 2 diabetes in UK European Whites, Indian Asians and Afro-Caribbean men and women. J Mol Med 84:1–10

Damcott CM, Pollin TI, Reinhart LJ et al (2006) Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance. Diabetes 55:2654–2659

Florez JC, Jablonski KA, Bayley N et al (2006) TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 355:241–250

Zhang C, Qi L, Hunter DJ et al (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene and the risk of type 2 diabetes in large cohorts of U.S. women and men. Diabetes 55:2645–2648

Marzi C, Huth C, Kolz M et al (2007) Variants of the transcription factor 7-like 2 gene (TCF7L2) are strongly associated with type 2 diabetes but not with the metabolic syndrome in the MONICA/KORA Surveys. Horm Metab Res 39:46–52

Melzer D, Murray A, Hurst AJ et al (2006) Effects of the diabetes linked TCF7L2 polymorphism in a representative older population. BMC Med 4:34 DOI 10.1186/1741-7015-4-34

Mayans S, Lackovic K, Lindgren P et al (2007) TCF7L2 polymorphisms are associated with type 2 diabetes in northern Sweden. Eur J Hum Genet 15:342–346

Lehman DM, Hunt KJ, Leach RJ et al (2007) Haplotypes of transcription factor 7-like 2 (TCF7L2) gene and its upstream region are associated with type 2 diabetes and age of onset in Mexican Americans. Diabetes 56:389–393

Chandak GR, Janipalli CS, Bhaskar S et al (2007) Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population. Diabetologia 50:63–67

Horikoshi M, Hara K, Ito C et al (2007) A genetic variation of the transcription factor 7-like 2 gene is associated with risk of type 2 diabetes in the Japanese population. Diabetologia 50:747–751

Hayashi T, Iwamoto Y, Kaku K et al (2007) Replication study for the association of TCF7L2 with susceptibility to type 2 diabetes in a Japanese population. Diabetologia 50:980–984 (Electronic publication ahead of print)

Helgason A, Palsson S, Thorleifsson G et al (2007) Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet 39:218–225

Oberkofler H, Linnemayr V, Weitgasser R et al (2004) Complex haplotypes of the PGC-1alpha gene are associated with carbohydrate metabolism and type 2 diabetes. Diabetes 53:1385–1393

Altshuler D, Hirschhorn JN, Klannemark M et al (2000) The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26:76–80

Barroso I, Luan J, Sandhu MS et al (2006) Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes. Diabetologia 49:501–505

Gloyn AL, Weedon MN, Owen KR et al (2003) Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 52:568–572

Love-Gregory L, Wasson J, Lin J et al (2003) E23K single nucleotide polymorphism in the islet ATP-sensitive potassium channel gene (Kir6.2) contributes as much to the risk of Type II diabetes in Caucasians as the PPARgamma Pro12Ala variant. Diabetologia 46:136–137

Weedon MN, Schwarz PE, Horikawa Y et al (2003) Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility. Am J Hum Genet 73:1208–1212

Tsuchiya T, Schwarz PE, Bosque-Plata LD et al (2006) Association of the calpain-10 gene with type 2 diabetes in Europeans: results of pooled and meta-analyses. Mol Genet Metab 89:174–184

Weedon MN, Owen KR, Shields B et al (2005) A large-scale association analysis of common variation of the HNF1alpha gene with type 2 diabetes in the U.K. Caucasian population. Diabetes 54:2487–2491

Weedon MN, Shields B, Hitman G et al (2006) No evidence of association of ENPP1 variants with type 2 diabetes or obesity in a study of 8,089 U.K. Caucasians. Diabetes 55:3175–3179

Qi L, van Dam RM, Meigs1 JB et al (2006) Genetic variation in IL6 gene and type 2 diabetes: tagging-SNP haplotype analysis in large-scale case-control study and meta-analysis. Hum Mol Genet 15:1914–1920

Huth C, Heid IM, Vollmert C et al (2006) IL6 gene promoter polymorphisms and type 2 diabetes: joint analysis of individual participants’ data from 21 studies. Diabetes 55:2915–2921

Zeggini E, McCarthy MI (2007) TCF7L2: the biggest story in diabetes genetics since HLA? Diabetologia 50:1–4

Wang QM, Zhang Y, Yang KM et al (2006) Wnt/beta-catenin signaling pathway is active in pancreatic development of rat embryo. World J Gastroenterol 12:2615–2619

Wells JM, Esni F, Boivin GP et al (2007) Wnt/Beta-catenin signaling is required for development of the exocrine pancreas. BMC Dev Biol 7:4

Yang Q, Khoury MJ, Friedman J et al (2005) How many genes underlie the occurrence of common complex diseases in the population? Int J Epidemiol 34:1129–1137

Sladek R, Rocheleau G, Rung J et al (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445:881–885

Agresti A (2002) Categorical data analysis. Wiley, New York

Higgins JP, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560

Egger M, Davey Smith G, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634